期刊
AMERICAN JOURNAL OF GASTROENTEROLOGY
卷 108, 期 5, 页码 679-692出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1038/ajg.2013.71
关键词
-
资金
- AstraZeneca
- Meritage Pharma
- ACG
- AGA
- NIH
- CURED Foundation
- Nutricia
- North American Society of Pediatric Gastroenterology, Hepatology and Nutrition
Esophageal eosinophilia and eosinophilic esophagitis (EoE) are increasingly recognized and prevalent conditions, which now represent common clinical problems encountered by gastroenterologists, pathologists, and allergists. The study of EoE has become a dynamic field with an evolving understanding of the pathogenesis, diagnosis, and treatment. Although there are limited data supporting management decisions, clinical parameters are needed to guide the care of patients with eosinophilic-esophageal disorders. In this evidence-based review, recommendations developed by adult and pediatric gastroenterologists are provided for the evaluation and management of these patients. New terminology is emphasized, particularly the concepts of esophageal eosinophilia and proton-pump inhibitor-responsive esophageal eosinophilia (PPI-REE) as entities distinct from EoE.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据